این سایت در حال حاضر پشتیبانی نمی شود و امکان دارد داده های نشریات بروز نباشند
صفحه اصلی
درباره پایگاه
فهرست سامانه ها
الزامات سامانه ها
فهرست سازمانی
تماس با ما
JCR 2016
جستجوی مقالات
چهارشنبه 19 آذر 1404
Journal of Medical Microbiology and Infectious Diseases
، جلد ۱۳، شماره ۲، صفحات ۱۴۷-۱۵۵
عنوان فارسی
چکیده فارسی مقاله
کلیدواژههای فارسی مقاله
عنوان انگلیسی
Antimicrobial Susceptibility Trends in Uropathogens: A 6-Year Retrospective Study from Kerala, India
چکیده انگلیسی مقاله
Introduction
: Antimicrobial resistance (AMR) among uropathogens is a critical global public health challenge, potentially exacerbated by the COVID-19 pandemic. This study evaluates the pandemic’s impact on antimicrobial susceptibility trends among uropathogens at a tertiary care center in Kerala over six years (2018–2023).
Methods:
A retrospective analysis of 4,461 uropathogen isolates was conducted using data from laboratory records. Data were analyzed using IBM SPSS Statistics version 20, with Chi-square tests for associations.
Results:
Escherichia coli
was the predominant pathogen (57.4%), followed by
Klebsiella pneumoniae
(14.3%) and
Enterococcus
spp. (6.0%). Other common isolates included
Pseudomonas aeruginosa
(4.2%) and
Acinetobacter baumannii
(3.3%), and fungi (6.8%).
E. coli
susceptibility to ampicillin increased significantly from 3.4% in 2018 to 13.9% in 2023 (
P
< 0.001), though overall resistance remained high; while susceptibility to cefoperazone-sulbactam and piperacillin-tazobactam declined (
P
< 0.001).
K. pneumoniae
susceptibility to cefoperazone-sulbactam decreased from 88.7% in 2018 to 73.0% in 2023 (
P
< 0.001).
Enterococcus
spp. susceptibility to nitrofurantoin declined from 91.0% in 2018 to 67.4% in 2023 (
P
= 0.017).
A. baumannii
showed increased ceftazidime susceptibility from 18.4% in 2018 to 56.0% in 2022, followed by a decline to 27.8% in 2023 (
P
= 0.015).
P. aeruginosa
exhibited increased susceptibility to gentamicin (57.6% to 77.2%;
P
= 0.012), ceftazidime (61.6% to 77.2%;
P
= 0.043), and fluoroquinolones (53.9% to 68.1%;
P
= 0.019) from 2018 to 2023.
Conclusion:
This study highlights dynamic shifts in antimicrobial susceptibility patterns among uropathogens, underscoring the need for continuous surveillance to guide empirical therapy and infection control strategies. Further research is warranted to explore contributing factors, including pandemic-related practices.
کلیدواژههای انگلیسی مقاله
Uropathogens, COVID-19, Antibiotic susceptibility, Drug resistance, Urinary tract infections, Kerala, India
نویسندگان مقاله
| Sheeba Pookkottu Madom
Department of Microbiology, Government Medical College, Palakkad, Kerala, India
| Roshni K Jose
Department of Microbiology, Government Medical College, Palakkad, Kerala, India
| Sreeram Balachandran
Department of General Medicine, Government Medical College, Palakkad, Kerala, India
| Deepak KS
Department of Preventive and Social Medicine, Government Medical College, Palakkad, Kerala, India
| Anila A Mathews
Department of Microbiology, Government Medical College, Palakkad, Kerala, India
نشانی اینترنتی
http://jommid.pasteur.ac.ir/browse.php?a_code=A-10-607-1&slc_lang=en&sid=1
فایل مقاله
فایلی برای مقاله ذخیره نشده است
کد مقاله (doi)
زبان مقاله منتشر شده
en
موضوعات مقاله منتشر شده
Microbial pathogenesis
نوع مقاله منتشر شده
Original article
برگشت به:
صفحه اول پایگاه
|
نسخه مرتبط
|
نشریه مرتبط
|
فهرست نشریات